公开(公告)号：US20050042308A1

公开(公告)日：2005-02-24

申请号：US10494143

申请日：2002-09-05

申请人： Wei Xiao ,  Yin Yang ,  Ya Ling ,  Minghui Li ,  Zhenggen Liao ,  Chenfeng Zhang ,  Shubo Cao

发明人： Wei Xiao ,  Yin Yang ,  Ya Ling ,  Minghui Li ,  Zhenggen Liao ,  Chenfeng Zhang ,  Shubo Cao

IPC分类号： G01N33/15 ,  A61K36/00 ,  A61K36/185 ,  A61K36/315 ,  A61K36/355 ,  A61K36/534 ,  A61K36/539 ,  A61K36/87 ,  A61P1/16 ,  A61P21/00 ,  A61P21/02 ,  A61P25/04 ,  A61P29/00 ,  A61P31/00 ,  A61P31/04 ,  G01N30/88 ,  G01N30/90 ,  A61K35/78

CPC分类号： A61K36/185 ,  A61K36/315 ,  A61K36/355 ,  A61K36/534 ,  A61K36/539 ,  A61K2300/00

摘要： The invention publishes a kind of drug complex with cholagogue and lithontriptic effect and its preparation method; the invention also publishes a kind of quality-control method of a kind of drug complex soft capsule. The invention drug complex is composed by the main materials of mint oil and herit oil. The aforementioned drug is mixed uniformly according to certain proportion, and can be added into conventional accessories to prepare into clinically accepted forms of drug, such as pill, tablet, orally-taken liquid preparation, capsule, granule et al. To control the drug quality according to the quality-control method of the soft-capsule-form drug publicized in the invention, good product stability and high repeatability can be acquired; The invention drug complex has distinct cholagogue, lithontriptic, anti-inflammation, analgesic effect through the pharmacological experiment.

摘要翻译： 本发明公开了一种具有胆碱和药物作用的药物复合物及其制备方法; 本发明还公开了一种药物复合软胶囊的一种质量控制方法。 本发明药物复合体由薄荷油和乳酸油的主要成分组成。 上述药物按一定比例均匀混合，可加入常规配件中，制备成临床接受的药物，如丸剂，片剂，口服液制剂，胶囊剂，颗粒剂等。 根据本发明公开的软胶囊形式药物的质量控制方法控制药物质量，可以获得良好的产品稳定性和高重复性; 本发明药物复合物通过药理实验具有明显的胆碱，溶栓，抗炎，镇痛作用。